- Description
- Specifications
The Australian Government has committed capital of $250 million to establish the Biomedical Translation Fund (BTF). The Department of Health has administrative responsibility for the BTF and is working together with the Department of Industry, Innovation and Science (Departments) to implement the BTF Programme.
Decisions under the BTF Programme are made by Innovation and Science Australia and the Programme Delegate appointed by the Minister for Industry, Innovation and Science in accordance with these Guidelines. The Department of Health will retain policy oversight for the programme to ensure the BTF delivers better health outcomes, and supports health and medical research and innovation.
This paper gives an overview of the Biomedical Translation Fund and has been written under the following headings:
- Introduction
- Objective
- Role of Innovation and Science Australia
- Role of the Programme Delegate
- How Will The BTF Operate?
- Eligible Investments
- Eligible Applications
- Merit Criteria
- How to Apply
- Application Assessment
- Granting of Licenses
- Operational Requirements of Licensed Funds
- Capital
- Control of a Licensed Fund
- Provisions Relating to Changes within Licensed Funds
- Advisory Board
- Investment Period
- Eligible Investee Companies
- Structuring Investments made by Licensed Funds
- Reporting and Evaluation
- Default
- Term and Distributions - Professional Advice